Product Browser

Last updated: 2017/3/19

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

SERPING1 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00000710-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-SERPING1 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 55.2
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-SERPING1 antibody (H00000710-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00000710-T01
    SERPING1 transfected lysate.
    Western Blot
    QC Testing of H00000710-T01
    Lane 1: SERPING1 transfected lysate ( 55.2 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 710
  • Protein Accession#:
  • -
  • Gene Name:
  • SERPING1
  • Gene Alias:
  • C1IN,C1INH,C1NH,HAE1,HAE2
  • Gene Description:
  • serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
  • Gene Summary:
  • This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its protein inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. Deficiency of this protein is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq
  • Other Designations:
  • complement component 1 inhibitor,plasma protease C1 inhibitor,serine/cysteine proteinase inhibitor clade G member 1
  • RSS
  • YouTube
  • Linkedin
  • Facebook